ALDX
ALDX
NASDAQ · Biotechnology

Aldeyra Therapeutics Inc

$2.19
+0.38 (+20.99%)
As of Mar 23, 3:46 PM ET ·
Financial Highlights (FY 2025)
Revenue
34.78M
Net Income
5.77M
Gross Margin
58.9%
Profit Margin
16.6%
Rev Growth
+3.0%
D/E Ratio
0.16
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 58.9% 58.9% 58.9%
Operating Margin 23.6% 24.2% 26.6%
Profit Margin 16.6% 21.8% 20.7%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 34.78M 32.14M 39.05M
Gross Profit 20.49M 18.94M 23.01M
Operating Income 8.21M 7.76M 10.41M
Net Income 5.77M 7.01M 8.10M
Gross Margin 58.9% 58.9% 58.9%
Operating Margin 23.6% 24.2% 26.6%
Profit Margin 16.6% 21.8% 20.7%
Rev Growth +3.0% +6.5% +17.8%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 21.85M 18.55M 22.16M
Total Equity 134.79M 127.44M 137.28M
D/E Ratio 0.16 0.15 0.16
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 11.08M 11.55M 13.91M
Free Cash Flow 4.11M 3.56M 7.02M